TRPM8 receptor antagonist

This page covers all TRPM8 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TRPM8.

Targets

TRPM8

Phase 3 pipeline (1)

• CL-108 · Charleston Laboratories, Inc · Pain management
  CL-108 is a novel, orally administered, non-opioid, non-sedating, and non-addictive analgesic.